SCALA: a randomized phase I trial comparing subcutaneous and intravenous alemtuzumab in patients with progressive multiple sclerosis. - Montalban X; Rodriguez-Acevedo B; Nos C; Resina M; Forner M; Wu Y; Chirieac M (Therapeutic advances in neurological disorders, 2024)